IRIDEX CORP

IRIX ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $42.6M $41.6M $46.2M $42.8M $38.3M $33.9M $33.2M
Cost of Revenue $25.1M $26.1M $25.3M $21.4M $19.7M $17.5M $16.9M
Gross Profit $17.5M $15.5M $20.8M $21.4M $18.6M $16.3M $16.3M
Gross Margin 41.0% 37.3% 45.1% 50.0% 48.6% 48.3% 49.1%
Operating Expenses
Research & Development $4.0M $5.2M $5.4M $4.6M $3.7M $4.4M $3.9M
SG&A Expense $9.6M $8.8M $7.6M $6.0M $5.0M $4.9M $4.3M
Operating Income $-12.9M $-12.9M $-2.6M $2.6M $2.6M $-860.0K $1.9M
Operating Margin -30.2% -31.0% -5.6% 6.0% 6.9% -2.5% 5.8%
Interest Expense
Pretax Income $-12.8M $-13.0M $-2.7M $1.3M $2.3M $-270.0K $2.4M
Income Tax Expense $37.0K $-128.0K $9.1M $-8.7M $31.0K $-100.0K $297.0K
Net Income $-12.8M $-12.9M $-11.7M $10.0M $2.2M $1.4M $2.6M
Net Margin -30.1% -30.9% -25.4% 23.4% 5.8% 4.2% 7.9%
EPS (Basic) $-1.05 $-1.11 $-1.15 $1.01 $0.24 $0.16 $0.29
EPS (Diluted) $-1.05 $-1.11 $-1.15 $0.97 $0.22 $0.16 $0.26
Shares Outstanding (Basic) 12.2M 11.6M 10.2M 9.9M 10.0M 9.2M 8.9M 9.0M
Shares Outstanding (Diluted) 12.2M 11.6M 10.2M 10.4M 10.0M 10.1M 8.9M 10.2M
Dividends Per Share
← Newer Page 2 of 3 Older →